2024 annual financial data
Rigel Pharmaceuticals 2024 Operating margin
Rigel Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was 13.49%.
Operating income was 24,192,000 USD and net income was 17,485,000 USD.
Operating cash flow was 31,471,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 179,278,000 USD
- Operating income
- 24,192,000 USD
- Net income
- 17,485,000 USD
- Operating cash flow
- 31,471,000 USD